Which method should be chosen to estimate the oxygen cost of walking in post-stroke individuals?


Journal

Gait & posture
ISSN: 1879-2219
Titre abrégé: Gait Posture
Pays: England
ID NLM: 9416830

Informations de publication

Date de publication:
09 2021
Historique:
received: 14 01 2021
revised: 23 07 2021
accepted: 25 07 2021
pubmed: 7 8 2021
medline: 26 11 2021
entrez: 6 8 2021
Statut: ppublish

Résumé

The oxygen cost of walking (Cw) represents the energy expenditure involved in walking, which is a major concern when quantifying physical activity in stroke. Recent studies have reported that Cw may be estimated accurately with a prediction equation using the self-self-selected walking speed (S To evaluate the validity of Cw estimates according to different modalities of S Twenty-one stroke individuals in subacute phase who were able to walk without human aid were included. Cw was estimated from the walking speed measured during a 10-m walking test, a 6-minute walking test and a recording on a GaitRite system. The values of the Cw estimates were compared to those measured by a respiratory gas exchange analyzer (Metamax3b). The findings showed that there is no significant difference between the Cw measured by Metamax3b and the Cw estimates regardless of the modalities used to measure S in stroke survivors who are able to walk independently without human aid, the use of a 10-m walking test, a 6-minute walking test or a GaitRite recording can be considered validated for estimating Cw.

Sections du résumé

BACKGROUND
The oxygen cost of walking (Cw) represents the energy expenditure involved in walking, which is a major concern when quantifying physical activity in stroke. Recent studies have reported that Cw may be estimated accurately with a prediction equation using the self-self-selected walking speed (S
RESEARCH QUESTION
To evaluate the validity of Cw estimates according to different modalities of S
METHODS
Twenty-one stroke individuals in subacute phase who were able to walk without human aid were included. Cw was estimated from the walking speed measured during a 10-m walking test, a 6-minute walking test and a recording on a GaitRite system. The values of the Cw estimates were compared to those measured by a respiratory gas exchange analyzer (Metamax3b).
RESULTS
The findings showed that there is no significant difference between the Cw measured by Metamax3b and the Cw estimates regardless of the modalities used to measure S
SIGNIFICANCE
in stroke survivors who are able to walk independently without human aid, the use of a 10-m walking test, a 6-minute walking test or a GaitRite recording can be considered validated for estimating Cw.

Identifiants

pubmed: 34358758
pii: S0966-6362(21)00268-X
doi: 10.1016/j.gaitpost.2021.07.017
pii:
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

217-219

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Maxence Compagnat (M)

HAVAE EA6310 (Handicap, Aging, Autonomy, Environment), FIRAH, University of Limoges, 87042 Limoges, France; Department of Physical Medicine and Rehabilitation in the University Hospital Center, 87042 Limoges, France. Electronic address: maxence.compagnat@unilim.fr.

Stéphane Mandigout (S)

HAVAE EA6310 (Handicap, Aging, Autonomy, Environment), FIRAH, University of Limoges, 87042 Limoges, France.

Anaick Perrochon (A)

HAVAE EA6310 (Handicap, Aging, Autonomy, Environment), FIRAH, University of Limoges, 87042 Limoges, France.

Jean Yves Salle (JY)

HAVAE EA6310 (Handicap, Aging, Autonomy, Environment), FIRAH, University of Limoges, 87042 Limoges, France; Department of Physical Medicine and Rehabilitation in the University Hospital Center, 87042 Limoges, France.

Jean Christophe Daviet (JC)

HAVAE EA6310 (Handicap, Aging, Autonomy, Environment), FIRAH, University of Limoges, 87042 Limoges, France; Department of Physical Medicine and Rehabilitation in the University Hospital Center, 87042 Limoges, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH